Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

F-18 FDG PET/Cl Findings of Subcutaneous Panniculitis - like T- Cell lymphoma: A Case Report

피하 지방층염양 T-세포 림프종의 F-18 FDG PET/CT 소견

  • Kong, Eun-Jung (Departments of Nuclear Medicine Yeungnam University College of Medicine) ;
  • Cho, Ihn-Ho (Departments of Nuclear Medicine Yeungnam University College of Medicine) ;
  • Chun, Kyung-Ah (Departments of Nuclear Medicine Yeungnam University College of Medicine) ;
  • Bae, Yeung-Kyung (Departments of Pathology Yeungnam University College of Medicine) ;
  • Choi, Joon-Hyuk (Departments of Pathology Yeungnam University College of Medicine) ;
  • Hyun, Myung-Soo (Departments of Internal Medicine Yeungnam University College of Medicine)
  • 공은정 (영남대학교 의과대학 핵의학교실) ;
  • 조인호 (영남대학교 의과대학 핵의학교실) ;
  • 천경아 (영남대학교 의과대학 핵의학교실) ;
  • 배영경 (영남대학교 의과대학 병리학교실) ;
  • 최준혁 (영남대학교 의과대학 병리학교실) ;
  • 현명수 (영남대학교 의과대학 내과학교실)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

F-18 FDG PET is a metabolic imaging modality that is efficacious in staging and assessment of treatment response for variety of lymphomas. We report usefulness of F-18 FOG PET/Cl in evaluating severity of the disease and response to therapy in a patient with subcutaneous panniculitis- like T-cell lymphoma (SPTCL). Here we describe a case of SPTCL in 24-year-old man who had wide spread firm and tender nodular lesions with increased F-18 FOG uptake. After chemotherapy follow up F-18 FDG PET/CT image shows disseminated malignancy and then the patient died with hemophagocytic syndrome. This report suggests that F-18 FDG PET/CT may be useful in determining disease activity at the time of initial diagnosis, after treatment, and evaluating a suspected outcome of SPTCL.

Keywords

References

  1. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991;15:17-27 https://doi.org/10.1097/00000478-199101000-00002
  2. Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998;22:881-93 https://doi.org/10.1097/00000478-199807000-00010
  3. Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 2000;18:2908-25 https://doi.org/10.1200/JCO.2000.18.15.2908
  4. Go RS, Wester SM. Inmnunophenotypic and molecular feature, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma. A systematic analysis of 156 patients reported in the literature. Cancer 2004;101:1404-13 https://doi.org/10.1002/cncr.20502
  5. Willernze R, Meijer CJ. Classificatioin of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutatan Pathol 2006;33(suppl. 1):18-26
  6. Marzano AV, Berti E, Paulli M, Caputo R Cytophagocytic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma. Arch Dermatol 2000;136:889-96 https://doi.org/10.1001/archderm.136.7.889
  7. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classficaion for cutaneous lymphomas. Blood 2005;105:3768-85 https://doi.org/10.1182/blood-2004-09-3502
  8. Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC cutaneous lymphoma group study of 83 cases. Blood 2008;111:838-45 https://doi.org/10.1182/blood-2007-04-087288
  9. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology 1997;203:795-800 https://doi.org/10.1148/radiology.203.3.9169707
  10. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, et al. Extranodal malignant lymphoma: detection with FDG PET vs. CT. Radiology 1998;206:475-81 https://doi.org/10.1148/radiology.206.2.9457202
  11. Kostakoglu L, Goldsmith SJ. Positron emission tomography in lymphoma: comparison with computed tomography and gallium-67 single photon emission computed tomography. Clin Lymphoma 2000;1:67-74 https://doi.org/10.3816/CLM.2000.n.007
  12. Guay C, Lepine M, Verreault J, Benard F. Prognostic value of PET using $^{18}$F-FDG in Hodgkin's disease for post-treatment evaluation. J Nucl Med 2003;44:1225-31
  13. Kumar R, Xiu Y, Zhuang HM, Alavi A. $^{18}$F-fluorodeoxyglucosepositron emission tomography in evaluation of primary cutaneous lymphoma. Br J Dermatol 2006;155:357-63 https://doi.org/10.1111/j.1365-2133.2006.07367.x
  14. Kim YH, Kim HS, Kim SY, Hwang YJ, Seo JW, Lee JY, et al. MR Findings of subcutaneous panniculitis-like T-cell lymphoma: a case report. J Korean Radiol Soc 2007;57:479-82
  15. Valencak J, Becherer A, Der-Petrossian M, Trautinger F, Raderer M, Hoffmann M Positron emission tomography with [${18}$F] 2-fluoro-D-2-deoxyglucose in primary cutaneous T-cell lymphomas. Haematologica 2004;89:115-6
  16. Shapiro M, Yun M, Junkins-Hopkins JM, Vittorio CC, Schulman N, Saidman BH, et al. Assessment of tumor burden and treatment response by $^{18}$F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas. J Am Acad Dermatol 2002;47:623-8 https://doi.org/10.1067/mjd.2002.124076
  17. Rodriguez VR, Joshi A, Peng F, Rabah RM, Stockmann PT, Savasan S. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma. Pediatr Blood Cancer 2009;52:406-8 https://doi.org/10.1002/pbc.21805
  18. Ravizzini G, Meirelles GS, Horwitz SM, Grewal RK. F-18 FDG uptake in subcutaneous panniculitis-like T-cell lymphoma. Clin Nucl Med 2008;33:903-5 https://doi.org/10.1097/RLU.0b013e31818bf2c7